Divergence of Rho residue 43 impacts GEF activity by Sloan, Christina M., Quinn, Clancy V., Peters, Justin P., Farley, Janean, Goetzinger, Chris, Wernli, Molly, DeMali, Kris A., Ellerbroek, Shawn M.

Get full text

Rho Residue 43 is a Structural Determinant of GEF Activity and Selectivity by Goetzinger, Chris J., Sloan, Christina M., Quinn, Clancy V., Ellerbroek, Shawn M.

Get full text

SBOL Visual: A Graphical Language for Genetic Designs by Quinn, Jacqueline Y, Cox, 3rd, Robert Sidney, Adler, Aaron, Beal, Jacob, Bhatia, Swapnil, Cai, Yizhi, Chen, Joanna, Clancy, Kevin, Galdzicki, Michal, Hillson, Nathan J, Le Novère, Nicolas, Maheshwari, Akshay J, McLaughlin, James Alastair, Myers, Chris J, P, Umesh, Pocock, Matthew, Rodriguez, Cesar, Soldatova, Larisa, Stan, Guy-Bart V, Swainston, Neil, Wipat, Anil, Sauro, Herbert M

Get full text

Neurodegeneration in a novel invertebrate model system: Failed microtubule‐mediated cell adhesion and unraveling of macroglia by Fabian‐Fine, Ruth, Aiken, Anna M., Aug, Julia R., Boucher, Jason D., Butler, Danielle C., Clancy, Liam J., Clem, Shaun A., Crotty, Samantha C., Dalpe, Abigail M., Donzello‐Jewett, Elizabeth J., Galgay, Taylor M., Gillis, Bonnie K., Heinrich, Brigid W., Hines, Kai R., Kimmel, Jordan E., McGrath, Joseph M., Miles, Marissa M., Morey, Jordyn A., Ortiz, Isaiah A., Pham, Kevin Q., Quinn, Liam C., Radican, Colin J., Speidel, Nolan T., Thomas, Bailey J., Troisi, Angela R., Weiss, Joshua L., Wentzheimer, Kayne V., Weaver, Adam L.

Get full text

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro by O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, D I, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L

Get full text

PS1-24: Validation of AJCC TNM Staging for Breast Tumors Diagnosed Before 2004 in Cancer Registries by Kwan, M., Haque, R., Lee, V., Chung, J., Avila, C., Clancy, H., Quinn, V., Kushi, L.

Get full text

SBOL Visual: A Graphical Language for Genetic Designs: e1002310 by Quinn, Jacqueline Y, Cox III, Robert Sidney, Adler, Aaron, Beal, Jacob, Bhatia, Swapnil, Cai, Yizhi, Chen, Joanna, Clancy, Kevin, Galdzicki, Michal, Hillson, Nathan J, Novère, Nicolas Le, Maheshwari, Akshay J, McLaughlin, James Alastair, Myers, Chris J, P, Umesh, Pocock, Matthew, Rodriguez, Cesar, Soldatova, Larisa, Stan, Guy-Bart V, Swainston, Neil, Wipat, Anil, Sauro, Herbert M

Get full text

The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro by O'brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-schwarz, V A, Murali, R, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, Defazio, A, Quinn, Di, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L

Get full text

Erratum: The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro by O'Brien, P M, Davies, M J, Scurry, J P, Smith, A N, Barton, C A, Henderson, M J, Saunders, D N, Gloss, B S, Patterson, K I, Clancy, J L, Heinzelmann-Schwarz, V A, Murali, R, Scolyer, R A, Zeng, Y, Williams, E D, Scurr, L, DeFazio, A, Quinn, Di, Watts, C K W, Hacker, N F, Henshall, S M, Sutherland, R L

Get full text